FIGURES
Victor Aboyans
Published 2026-10-28
Victor Aboyans has 1,036 works and 500,779 citations. Research topics include Peripheral Artery Disease Management, Cardiovascular Health and Disease Prevention, Vascular Procedures and Complications, Blood Pressure and Hypertension Studies, Diabetes, Cardiovascular Risks, and Lipoproteins.
1,036 works500,779 citationsh-index 159
Selected research works
Up to 100 selected research works. Source updated 2026-10-28T13:16:14+00:00.
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 · 2020 · 19,327 citations
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 · 2012 · 14,070 citations
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure · 2021 · 13,342 citations
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 · 2017 · 13,219 citations
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure · 2016 · 11,436 citations
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 · 2020 · 11,431 citations
- 2018 ESC/ESH Guidelines for the management of arterial hypertension · 2018 · 10,290 citations
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) · 2020 · 9,995 citations
- Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 · 2020 · 9,842 citations
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation · 2017 · 9,725 citations
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk · 2019 · 8,963 citations
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 · 2012 · 8,889 citations
- European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) · 2012 · 8,494 citations
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 · 2012 · 8,293 citations
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation · 2015 · 8,264 citations
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes · 2019 · 7,163 citations
- 2018 ESC/EACTS Guidelines on myocardial revascularization · 2018 · 7,163 citations
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension · 2015 · 6,934 citations
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice · 2021 · 6,485 citations
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice · 2016 · 6,454 citations
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS · 2016 · 6,422 citations
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 · 2015 · 6,414 citations
- 2017 ESC/EACTS Guidelines for the management of valvular heart disease · 2017 · 6,232 citations
- Fourth universal definition of myocardial infarction (2018) · 2018 · 5,895 citations
- Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 · 2019 · 5,635 citations
- 2023 ESC Guidelines for the management of acute coronary syndromes · 2023 · 5,313 citations
- 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation · 2020 · 5,036 citations
- 2015 ESC Guidelines for the management of infective endocarditis · 2015 · 4,984 citations
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) · 2019 · 4,903 citations
- 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk · 2019 · 4,854 citations
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 · 2017 · 4,824 citations
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD · 2019 · 4,762 citations
- 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases · 2014 · 4,451 citations
- Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 · 2018 · 4,086 citations
- 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension · 2022 · 4,029 citations
- 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death · 2015 · 3,896 citations
- Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 · 2018 · 3,523 citations
- Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis · 2013 · 3,504 citations
- 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) · 2017 · 3,292 citations
- 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death · 2022 · 3,193 citations
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias · 2016 · 3,164 citations
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) · 2022 · 3,139 citations
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS · 2017 · 2,988 citations
- 2018 ESC/ESH Guidelines for the management of arterial hypertension · 2018 · 2,884 citations
- 2023 ESC Guidelines for the management of cardiomyopathies · 2023 · 2,791 citations
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 · 2015 · 2,700 citations
- 2015 ESC Guidelines for the diagnosis and management of pericardial diseases · 2015 · 2,634 citations
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines · 2016 · 2,541 citations
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 · 2017 · 2,406 citations
- 2020 ESC Guidelines for the management of adult congenital heart disease · 2020 · 2,324 citations
- 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy · 2018 · 2,290 citations
- Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 · 2017 · 2,080 citations
- Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 · 2024 · 2,076 citations
- 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy · 2021 · 2,013 citations
- Global vascular guidelines on the management of chronic limb-threatening ischemia · 2019 · 2,011 citations
- Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition · 2015 · 1,966 citations
- 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease · 2020 · 1,955 citations
- 2018 ESC Guidelines for the diagnosis and management of syncope · 2018 · 1,944 citations
- 2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines · 2016 · 1,795 citations
- Epidemiology of Peripheral Artery Disease · 2015 · 1,784 citations
- Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 · 2021 · 1,759 citations
- Measurement and Interpretation of the Ankle-Brachial Index · 2012 · 1,738 citations
- 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes · 2023 · 1,634 citations
- Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia · 2019 · 1,576 citations
- ESC Guidelines on the diagnosis and treatment of peripheral artery diseases · 2011 · 1,507 citations
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice · 2016 · 1,401 citations
- Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 · 2012 · 1,323 citations
- 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) · 2019 · 1,230 citations
- Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 · 2018 · 1,210 citations
- Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 · 2016 · 1,162 citations
- 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery · 2022 · 1,151 citations
- Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 · 2018 · 1,011 citations
- 2018 ESC/EACTS Guidelines on myocardial revascularization · 2018 · 993 citations
- Editor's Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) · 2017 · 958 citations
- 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy · 2021 · 921 citations
- Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study · 2019 · 913 citations
- 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension · 2018 · 883 citations
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial · 2017 · 879 citations
- Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association · 2021 · 822 citations
- Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 · 2016 · 771 citations
- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial · 2017 · 754 citations
- Peripheral artery disease: epidemiology and global perspectives · 2016 · 736 citations
- The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation · 2015 · 718 citations
- 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension · 2018 · 709 citations
- Five insights from the Global Burden of Disease Study 2019 · 2020 · 678 citations
- 2017 ESC/EACTS Guidelines for the management of valvular heart disease · 2017 · 629 citations
- The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. · 2015 · 590 citations
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice · 2021 · 546 citations
- Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017 · 2018 · 539 citations
- [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. · 2018 · 527 citations
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) · 2022 · 513 citations
- Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990–2017 · 2020 · 492 citations
- Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 · 2018 · 486 citations
- Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease · 2018 · 466 citations
- 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases · 2014 · 458 citations
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 · 2020 · 432 citations
- EACTS/STS Guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ · 2023 · 423 citations
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS · 2017 · 409 citations
- Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function · 2017 · 402 citations
- Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis · 2020 · 399 citations